BioSight
Companies
ORAMED PHARMACEUTICALS INC. logo

ORMP

NASDAQNEW YORK, NY
ORAMED PHARMACEUTICALS INC.

Oramed Pharmaceuticals develops oral drug delivery technologies and therapeutics, with a focus on treatments for metabolic and gastrointestinal diseases. The firm is in early-to-mid stage development, pursuing oral formulations of drugs that are typically administered by injection or other routes. Oramed also holds financial investments in real estate projects and warrants in other biotech entities.

Price history not yet available for ORMP.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar